ReviewFrontiers in nutrition2026
Agricultural chemicals and gut microbiota dysbiosis: implications for the pathogenesis of inflammatory bowel disease.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global intensification of agriculture has substantially increased human exposure to foodborne and environmental contaminants, including pesticides, heavy metals, endocrine-disrupting chemicals (EDCs), mycotoxins, and fertilizer-related related agricultural exposures. Growing evidence suggests that these agricultural xenobiotics may contribute to inflammatory bowel disease (IBD) pathogenesis through alterations of gut microbiota composition and function. This review examines the current evidence linking major agricultural contaminants to gut microbiota dysbiosis, intestinal barrier dysfunction, immune dysregulation, and chronic intestinal inflammation. Experimental and epidemiological studies indicate that chronic exposure to these compounds may reduce microbial diversity, alter the abundance of beneficial bacterial populations, impair short-chain fatty acid production, and activate oxidative stress and pro-inflammatory signaling pathways, including NF-κB and MAPK-related mechanisms. These alterations may collectively promote epithelial barrier disruption and aberrant mucosal immune activation, which are central processes in IBD pathogenesis. Attention is given to the role of dietary exposure and food-chain contamination as potential mediators of environmentally driven intestinal inflammation. Although most currently available evidence derives from
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.